Norway - Norway - Statens legemiddelverk

h. lundbeck a/s - klorprotiksenhydroklorid - tablett, filmdrasjert - 50 mg

Norway - Norway - Statens legemiddelverk

pfizer as - linezolid - tablett, filmdrasjert - 600 mg

Norway - Norway - Statens legemiddelverk

krka, d.d. novo mesto - linezolid - tablett, filmdrasjert - 600 mg

Norway - Norway - Statens legemiddelverk

accord healthcare b.v. - linezolid - infusjonsvæske, oppløsning - 2 mg/ ml

Kesatuan Eropah - Norway - EMA (European Medicines Agency)

secura bio limited - duvelisib - leukemia, lymphocytic, chronic, b-cell; lymphoma, follicular - antineoplastiske midler - copiktra monotherapy is indicated for the treatment of adult patients with: relapsed or refractory chronic lymphocytic leukaemia (cll) after at least two prior therapies.  follicular lymphoma (fl) that is refractory to at least two prior  systemic therapies.

Kesatuan Eropah - Norway - EMA (European Medicines Agency)

seagen b.v. - tucatinib - breast neoplasms; neoplasm metastasis - antineoplastiske midler - tukysa is indicated in combination with trastuzumab and capecitabine for the treatment of adult patients with her2‑positive locally advanced or metastatic breast cancer who have received at least 2 prior anti‑her2 treatment regimens.

Norway - Norway - Statens legemiddelverk

macure pharma aps - verapamilhydroklorid - injeksjons-/infusjonsvæske, oppløsning - 2.5 mg/ ml

Norway - Norway - Statens legemiddelverk

orifarm as - benzoylperoksid, vandig - gel - 5 %

Norway - Norway - Statens legemiddelverk

orifarm as - benzoylperoksid, vandig - gel - 10 %

Kesatuan Eropah - Norway - EMA (European Medicines Agency)

merck sharp & dohme b.v. - indinavir sulfat ethanolate - hiv-infeksjoner - antivirale midler til systemisk bruk - crixivan er angitt i kombinasjon med antiretrovirale nukleosidanaloger for behandling av hiv-1-infiserte voksne.